Pharmaceutical firm HLB Co. said Wednesday it plans to list its shares on the main bourse, defecting from the secondary KOSDAQ market.
HLB has signed a contract with Korea Investment & Securities Co. to move to the Korea Exchange, the company said in a regulatory filing, without elaborating on when it will list its shares on the main bourse.
HLB is the sixth-largest company on the KOSDAQ in terms of market capitalization and worth about 4 trillion won (US$3 billion).
Source: Yonhap News Agency